Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2001

01-08-2001 | Case Report

A case of spindle cell carcinoma of the breast-long survival achieved by multiple surgical treatment

Authors: Shunichi Okushiba, Hidehiko Minagawa, Michio Shimizu, Yoshiyasu Ambo, Mitsuhito Kaji, Makoto Omi, Kiyotaka Itoh, Satoshi Kondo, Hiroyuki Katoh

Published in: Breast Cancer | Issue 3/2001

Login to get access
Metadata
Title
A case of spindle cell carcinoma of the breast-long survival achieved by multiple surgical treatment
Authors
Shunichi Okushiba
Hidehiko Minagawa
Michio Shimizu
Yoshiyasu Ambo
Mitsuhito Kaji
Makoto Omi
Kiyotaka Itoh
Satoshi Kondo
Hiroyuki Katoh
Publication date
01-08-2001
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2001
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967515

Other articles of this Issue 3/2001

Breast Cancer 3/2001 Go to the issue

Case Report

A case of basal cell carcinoma of the nipple and areola with intraductal spread

Case Report

A case of muscular hamartoma of the breast

Letters to the Editor

Author’ reply

]Letters to the Editor

Recurrence of breast cancer fallowing local excision alone for ductal carcinomain situ

Case Report

Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicin

Review Article

The role of c-erbB-2 as a predictive factor in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits